Industry Research Reports

Home > Reports > Pharma & Healthcare > Global Mucin 1 Market Research Report 2024

Global Mucin 1 Market Research Report 2024

Industry: Pharma & Healthcare

Published Date: 2024-01-08

Pages: 81 Pages

Report ld: 2722558

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global Mucin 1 market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Mucin 1 is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Mucin 1 is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Mucin 1 include Akshaya Bio Inc, Bavarian Nordic A/S, Boehringer Ingelheim GmbH, Etubics Corp, GeoVax Labs Inc, Merck KGaA, Minerva Biotechnologies Corp, Transgene SA and Vaxil Bio Therapeutics Ltd, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Mucin 1, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mucin 1.

MARKET SEGMENTATION

By Company

Akshaya Bio Inc
Bavarian Nordic A/S
Boehringer Ingelheim GmbH
Etubics Corp
GeoVax Labs Inc
Merck KGaA
Minerva Biotechnologies Corp
Transgene SA
Vaxil Bio Therapeutics Ltd

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

TG-4010
GO-2032c
ImMucin
BI-1361849
Others

Segment by Application

Prostate Cancer
Breast Cancer
Colon Cancer
Ovarian Cancer
Others

biaoTi REPORT SCOPE

The Mucin 1 market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Mucin 1 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Mucin 1 manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Mucin 1 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Mucin 1 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Mucin 1 Market Overview

1.1 Product Overview and Scope of Mucin 1

1.2 Mucin 1 Segment by Type

1.2.1 Global Mucin 1 Market Value Comparison by Type (2024-2030)

1.2.2 TG-4010

1.2.3 GO-2032c

1.2.4 ImMucin

1.2.5 BI-1361849

1.2.6 Others

1.3 Mucin 1 Segment by Application

1.3.1 Global Mucin 1 Market Value by Application: (2024-2030)

1.3.2 Prostate Cancer

1.3.3 Breast Cancer

1.3.4 Colon Cancer

1.3.5 Ovarian Cancer

1.3.6 Others

1.4 Global Mucin 1 Market Size Estimates and Forecasts

1.4.1 Global Mucin 1 Revenue 2019-2030

1.4.2 Global Mucin 1 Sales 2019-2030

1.4.3 Global Mucin 1 Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Mucin 1 Market Competition by Manufacturers

2.1 Global Mucin 1 Sales Market Share by Manufacturers (2019-2024)

2.2 Global Mucin 1 Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Mucin 1 Average Price by Manufacturers (2019-2024)

2.4 Global Mucin 1 Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Mucin 1, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Mucin 1, Product Type & Application

2.7 Mucin 1 Market Competitive Situation and Trends

2.7.1 Mucin 1 Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Mucin 1 Players Market Share by Revenue

2.7.3 Global Mucin 1 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Mucin 1 Retrospective Market Scenario by Region

3.1 Global Mucin 1 Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Mucin 1 Global Mucin 1 Sales by Region: 2019-2030

3.2.1 Global Mucin 1 Sales by Region: 2019-2024

3.2.2 Global Mucin 1 Sales by Region: 2025-2030

3.3 Global Mucin 1 Global Mucin 1 Revenue by Region: 2019-2030

3.3.1 Global Mucin 1 Revenue by Region: 2019-2024

3.3.2 Global Mucin 1 Revenue by Region: 2025-2030

3.4 North America Mucin 1 Market Facts & Figures by Country

3.4.1 North America Mucin 1 Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Mucin 1 Sales by Country (2019-2030)

3.4.3 North America Mucin 1 Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Mucin 1 Market Facts & Figures by Country

3.5.1 Europe Mucin 1 Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Mucin 1 Sales by Country (2019-2030)

3.5.3 Europe Mucin 1 Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Mucin 1 Market Facts & Figures by Country

3.6.1 Asia Pacific Mucin 1 Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Mucin 1 Sales by Country (2019-2030)

3.6.3 Asia Pacific Mucin 1 Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Mucin 1 Market Facts & Figures by Country

3.7.1 Latin America Mucin 1 Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Mucin 1 Sales by Country (2019-2030)

3.7.3 Latin America Mucin 1 Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Mucin 1 Market Facts & Figures by Country

3.8.1 Middle East and Africa Mucin 1 Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Mucin 1 Sales by Country (2019-2030)

3.8.3 Middle East and Africa Mucin 1 Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Mucin 1 Sales by Type (2019-2030)

4.1.1 Global Mucin 1 Sales by Type (2019-2024)

4.1.2 Global Mucin 1 Sales by Type (2025-2030)

4.1.3 Global Mucin 1 Sales Market Share by Type (2019-2030)

4.2 Global Mucin 1 Revenue by Type (2019-2030)

4.2.1 Global Mucin 1 Revenue by Type (2019-2024)

4.2.2 Global Mucin 1 Revenue by Type (2025-2030)

4.2.3 Global Mucin 1 Revenue Market Share by Type (2019-2030)

4.3 Global Mucin 1 Price by Type (2019-2030)

5 Segment by Application

5.1 Global Mucin 1 Sales by Application (2019-2030)

5.1.1 Global Mucin 1 Sales by Application (2019-2024)

5.1.2 Global Mucin 1 Sales by Application (2025-2030)

5.1.3 Global Mucin 1 Sales Market Share by Application (2019-2030)

5.2 Global Mucin 1 Revenue by Application (2019-2030)

5.2.1 Global Mucin 1 Revenue by Application (2019-2024)

5.2.2 Global Mucin 1 Revenue by Application (2025-2030)

5.2.3 Global Mucin 1 Revenue Market Share by Application (2019-2030)

5.3 Global Mucin 1 Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Akshaya Bio Inc

6.1.1 Akshaya Bio Inc Corporation Information

6.1.2 Akshaya Bio Inc Description and Business Overview

6.1.3 Akshaya Bio Inc Mucin 1 Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Akshaya Bio Inc Mucin 1 Product Portfolio

6.1.5 Akshaya Bio Inc Recent Developments/Updates

6.2 Bavarian Nordic A/S

6.2.1 Bavarian Nordic A/S Corporation Information

6.2.2 Bavarian Nordic A/S Description and Business Overview

6.2.3 Bavarian Nordic A/S Mucin 1 Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Bavarian Nordic A/S Mucin 1 Product Portfolio

6.2.5 Bavarian Nordic A/S Recent Developments/Updates

6.3 Boehringer Ingelheim GmbH

6.3.1 Boehringer Ingelheim GmbH Corporation Information

6.3.2 Boehringer Ingelheim GmbH Description and Business Overview

6.3.3 Boehringer Ingelheim GmbH Mucin 1 Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Boehringer Ingelheim GmbH Mucin 1 Product Portfolio

6.3.5 Boehringer Ingelheim GmbH Recent Developments/Updates

6.4 Etubics Corp

6.4.1 Etubics Corp Corporation Information

6.4.2 Etubics Corp Description and Business Overview

6.4.3 Etubics Corp Mucin 1 Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Etubics Corp Mucin 1 Product Portfolio

6.4.5 Etubics Corp Recent Developments/Updates

6.5 GeoVax Labs Inc

6.5.1 GeoVax Labs Inc Corporation Information

6.5.2 GeoVax Labs Inc Description and Business Overview

6.5.3 GeoVax Labs Inc Mucin 1 Sales, Revenue and Gross Margin (2019-2024)

6.5.4 GeoVax Labs Inc Mucin 1 Product Portfolio

6.5.5 GeoVax Labs Inc Recent Developments/Updates

6.6 Merck KGaA

6.6.1 Merck KGaA Corporation Information

6.6.2 Merck KGaA Description and Business Overview

6.6.3 Merck KGaA Mucin 1 Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Merck KGaA Mucin 1 Product Portfolio

6.6.5 Merck KGaA Recent Developments/Updates

6.7 Minerva Biotechnologies Corp

6.6.1 Minerva Biotechnologies Corp Corporation Information

6.6.2 Minerva Biotechnologies Corp Description and Business Overview

6.6.3 Minerva Biotechnologies Corp Mucin 1 Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Minerva Biotechnologies Corp Mucin 1 Product Portfolio

6.7.5 Minerva Biotechnologies Corp Recent Developments/Updates

6.8 Transgene SA

6.8.1 Transgene SA Corporation Information

6.8.2 Transgene SA Description and Business Overview

6.8.3 Transgene SA Mucin 1 Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Transgene SA Mucin 1 Product Portfolio

6.8.5 Transgene SA Recent Developments/Updates

6.9 Vaxil Bio Therapeutics Ltd

6.9.1 Vaxil Bio Therapeutics Ltd Corporation Information

6.9.2 Vaxil Bio Therapeutics Ltd Description and Business Overview

6.9.3 Vaxil Bio Therapeutics Ltd Mucin 1 Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Vaxil Bio Therapeutics Ltd Mucin 1 Product Portfolio

6.9.5 Vaxil Bio Therapeutics Ltd Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Mucin 1 Industry Chain Analysis

7.2 Mucin 1 Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Mucin 1 Production Mode & Process

7.4 Mucin 1 Sales and Marketing

7.4.1 Mucin 1 Sales Channels

7.4.2 Mucin 1 Distributors

7.5 Mucin 1 Customers

8 Mucin 1 Market Dynamics

8.1 Mucin 1 Industry Trends

8.2 Mucin 1 Market Drivers

8.3 Mucin 1 Market Challenges

8.4 Mucin 1 Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Mucin 1 Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Mucin 1 Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Mucin 1 Market Competitive Situation by Manufacturers in 2023

Table 4. Global Mucin 1 Sales (K Pcs) of Key Manufacturers (2019-2024)

Table 5. Global Mucin 1 Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Mucin 1 Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Mucin 1 Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Mucin 1 Average Price (USD/Pcs) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Mucin 1, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Mucin 1, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Mucin 1, Product Type & Application

Table 12. Global Key Manufacturers of Mucin 1, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Mucin 1 by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mucin 1 as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Mucin 1 Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Mucin 1 Sales by Region (2019-2024) & (K Pcs)

Table 18. Global Mucin 1 Sales Market Share by Region (2019-2024)

Table 19. Global Mucin 1 Sales by Region (2025-2030) & (K Pcs)

Table 20. Global Mucin 1 Sales Market Share by Region (2025-2030)

Table 21. Global Mucin 1 Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Mucin 1 Revenue Market Share by Region (2019-2024)

Table 23. Global Mucin 1 Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Mucin 1 Revenue Market Share by Region (2025-2030)

Table 25. North America Mucin 1 Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Mucin 1 Sales by Country (2019-2024) & (K Pcs)

Table 27. North America Mucin 1 Sales by Country (2025-2030) & (K Pcs)

Table 28. North America Mucin 1 Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Mucin 1 Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Mucin 1 Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Mucin 1 Sales by Country (2019-2024) & (K Pcs)

Table 32. Europe Mucin 1 Sales by Country (2025-2030) & (K Pcs)

Table 33. Europe Mucin 1 Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Mucin 1 Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Mucin 1 Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Mucin 1 Sales by Region (2019-2024) & (K Pcs)

Table 37. Asia Pacific Mucin 1 Sales by Region (2025-2030) & (K Pcs)

Table 38. Asia Pacific Mucin 1 Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Mucin 1 Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Mucin 1 Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Mucin 1 Sales by Country (2019-2024) & (K Pcs)

Table 42. Latin America Mucin 1 Sales by Country (2025-2030) & (K Pcs)

Table 43. Latin America Mucin 1 Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Mucin 1 Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Mucin 1 Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Mucin 1 Sales by Country (2019-2024) & (K Pcs)

Table 47. Middle East & Africa Mucin 1 Sales by Country (2025-2030) & (K Pcs)

Table 48. Middle East & Africa Mucin 1 Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Mucin 1 Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Mucin 1 Sales (K Pcs) by Type (2019-2024)

Table 51. Global Mucin 1 Sales (K Pcs) by Type (2025-2030)

Table 52. Global Mucin 1 Sales Market Share by Type (2019-2024)

Table 53. Global Mucin 1 Sales Market Share by Type (2025-2030)

Table 54. Global Mucin 1 Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Mucin 1 Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Mucin 1 Revenue Market Share by Type (2019-2024)

Table 57. Global Mucin 1 Revenue Market Share by Type (2025-2030)

Table 58. Global Mucin 1 Price (USD/Pcs) by Type (2019-2024)

Table 59. Global Mucin 1 Price (USD/Pcs) by Type (2025-2030)

Table 60. Global Mucin 1 Sales (K Pcs) by Application (2019-2024)

Table 61. Global Mucin 1 Sales (K Pcs) by Application (2025-2030)

Table 62. Global Mucin 1 Sales Market Share by Application (2019-2024)

Table 63. Global Mucin 1 Sales Market Share by Application (2025-2030)

Table 64. Global Mucin 1 Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Mucin 1 Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Mucin 1 Revenue Market Share by Application (2019-2024)

Table 67. Global Mucin 1 Revenue Market Share by Application (2025-2030)

Table 68. Global Mucin 1 Price (USD/Pcs) by Application (2019-2024)

Table 69. Global Mucin 1 Price (USD/Pcs) by Application (2025-2030)

Table 70. Akshaya Bio Inc Corporation Information

Table 71. Akshaya Bio Inc Description and Business Overview

Table 72. Akshaya Bio Inc Mucin 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 73. Akshaya Bio Inc Mucin 1 Product

Table 74. Akshaya Bio Inc Recent Developments/Updates

Table 75. Bavarian Nordic A/S Corporation Information

Table 76. Bavarian Nordic A/S Description and Business Overview

Table 77. Bavarian Nordic A/S Mucin 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 78. Bavarian Nordic A/S Mucin 1 Product

Table 79. Bavarian Nordic A/S Recent Developments/Updates

Table 80. Boehringer Ingelheim GmbH Corporation Information

Table 81. Boehringer Ingelheim GmbH Description and Business Overview

Table 82. Boehringer Ingelheim GmbH Mucin 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 83. Boehringer Ingelheim GmbH Mucin 1 Product

Table 84. Boehringer Ingelheim GmbH Recent Developments/Updates

Table 85. Etubics Corp Corporation Information

Table 86. Etubics Corp Description and Business Overview

Table 87. Etubics Corp Mucin 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 88. Etubics Corp Mucin 1 Product

Table 89. Etubics Corp Recent Developments/Updates

Table 90. GeoVax Labs Inc Corporation Information

Table 91. GeoVax Labs Inc Description and Business Overview

Table 92. GeoVax Labs Inc Mucin 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 93. GeoVax Labs Inc Mucin 1 Product

Table 94. GeoVax Labs Inc Recent Developments/Updates

Table 95. Merck KGaA Corporation Information

Table 96. Merck KGaA Description and Business Overview

Table 97. Merck KGaA Mucin 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 98. Merck KGaA Mucin 1 Product

Table 99. Merck KGaA Recent Developments/Updates

Table 100. Minerva Biotechnologies Corp Corporation Information

Table 101. Minerva Biotechnologies Corp Description and Business Overview

Table 102. Minerva Biotechnologies Corp Mucin 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 103. Minerva Biotechnologies Corp Mucin 1 Product

Table 104. Minerva Biotechnologies Corp Recent Developments/Updates

Table 105. Transgene SA Corporation Information

Table 106. Transgene SA Description and Business Overview

Table 107. Transgene SA Mucin 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 108. Transgene SA Mucin 1 Product

Table 109. Transgene SA Recent Developments/Updates

Table 110. Vaxil Bio Therapeutics Ltd Corporation Information

Table 111. Vaxil Bio Therapeutics Ltd Description and Business Overview

Table 112. Vaxil Bio Therapeutics Ltd Mucin 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 113. Vaxil Bio Therapeutics Ltd Mucin 1 Product

Table 114. Vaxil Bio Therapeutics Ltd Recent Developments/Updates

Table 115. Key Raw Materials Lists

Table 116. Raw Materials Key Suppliers Lists

Table 117. Mucin 1 Distributors List

Table 118. Mucin 1 Customers List

Table 119. Mucin 1 Market Trends

Table 120. Mucin 1 Market Drivers

Table 121. Mucin 1 Market Challenges

Table 122. Mucin 1 Market Restraints

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Mucin 1

Figure 2. Global Mucin 1 Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Mucin 1 Market Share by Type in 2023 & 2030

Figure 4. TG-4010 Product Picture

Figure 5. GO-2032c Product Picture

Figure 6. ImMucin Product Picture

Figure 7. BI-1361849 Product Picture

Figure 8. Others Product Picture

Figure 9. Global Mucin 1 Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 10. Global Mucin 1 Market Share by Application in 2023 & 2030

Figure 11. Prostate Cancer

Figure 12. Breast Cancer

Figure 13. Colon Cancer

Figure 14. Ovarian Cancer

Figure 15. Others

Figure 16. Global Mucin 1 Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 17. Global Mucin 1 Market Size (2019-2030) & (US$ Million)

Figure 18. Global Mucin 1 Sales (2019-2030) & (K Pcs)

Figure 19. Global Mucin 1 Average Price (USD/Pcs) & (2019-2030)

Figure 20. Mucin 1 Report Years Considered

Figure 21. Mucin 1 Sales Share by Manufacturers in 2023

Figure 22. Global Mucin 1 Revenue Share by Manufacturers in 2023

Figure 23. The Global 5 and 10 Largest Mucin 1 Players: Market Share by Revenue in 2023

Figure 24. Mucin 1 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 25. Global Mucin 1 Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 26. North America Mucin 1 Sales Market Share by Country (2019-2030)

Figure 27. North America Mucin 1 Revenue Market Share by Country (2019-2030)

Figure 28. U.S. Mucin 1 Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. Canada Mucin 1 Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Europe Mucin 1 Sales Market Share by Country (2019-2030)

Figure 31. Europe Mucin 1 Revenue Market Share by Country (2019-2030)

Figure 32. Germany Mucin 1 Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. France Mucin 1 Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. U.K. Mucin 1 Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Italy Mucin 1 Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. Russia Mucin 1 Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Asia Pacific Mucin 1 Sales Market Share by Region (2019-2030)

Figure 38. Asia Pacific Mucin 1 Revenue Market Share by Region (2019-2030)

Figure 39. China Mucin 1 Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Japan Mucin 1 Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. South Korea Mucin 1 Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. India Mucin 1 Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Australia Mucin 1 Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Taiwan Mucin 1 Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Indonesia Mucin 1 Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Thailand Mucin 1 Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Malaysia Mucin 1 Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Philippines Mucin 1 Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Latin America Mucin 1 Sales Market Share by Country (2019-2030)

Figure 50. Latin America Mucin 1 Revenue Market Share by Country (2019-2030)

Figure 51. Mexico Mucin 1 Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Brazil Mucin 1 Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. Argentina Mucin 1 Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. Middle East & Africa Mucin 1 Sales Market Share by Country (2019-2030)

Figure 55. Middle East & Africa Mucin 1 Revenue Market Share by Country (2019-2030)

Figure 56. Turkey Mucin 1 Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 57. Saudi Arabia Mucin 1 Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 58. UAE Mucin 1 Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 59. Global Sales Market Share of Mucin 1 by Type (2019-2030)

Figure 60. Global Revenue Market Share of Mucin 1 by Type (2019-2030)

Figure 61. Global Mucin 1 Price (USD/Pcs) by Type (2019-2030)

Figure 62. Global Sales Market Share of Mucin 1 by Application (2019-2030)

Figure 63. Global Revenue Market Share of Mucin 1 by Application (2019-2030)

Figure 64. Global Mucin 1 Price (USD/Pcs) by Application (2019-2030)

Figure 65. Mucin 1 Value Chain

Figure 66. Mucin 1 Production Process

Figure 67. Channels of Distribution (Direct Vs Distribution)

Figure 68. Distributors Profiles

Figure 69. Bottom-up and Top-down Approaches for This Report

Figure 70. Data Triangulation

Figure 71. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Mucin 1 market? zhanKai

The top companies in the global Mucin 1 market are Akshaya Bio Inc、Bavarian Nordic A/S、Boehringer Ingelheim GmbH.

Related Reports

Mucin 1- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Mucin 1 was estimated to be worth US$ 300 million in 2025 and is projected to reach US$ 620 million, growing at a CAGR of 10.8% from 2026 to 2032.
Published Date: 2026-05-30
Pages: 193
USD 3950.00
(Single User License)
Global Mucin 1 Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Mucin 1 market is projected to grow from US$ 300 million in 2025 to US$ 620 million by 2032, at a CAGR of 10.8% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-05-30
Pages: 240
USD 4900.00
(Single User License)
Global Mucin 1 Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Mucin 1 market size was US$ 300 million in 2025 and is forecast to reach a readjusted size of US$ 620 million by 2032 with a CAGR of 10.8% during the forecast period 2026-2032.
Published Date: 2026-05-30
Pages: 187
USD 4250.00
(Single User License)
Global Mucin 1 Market Research Report 2026
The global Mucin 1 market was valued at US$ 300 million in 2025 and is anticipated to reach US$ 620 million by 2032, at a CAGR of 10.8% from 2026 to 2032.
Published Date: 2026-05-30
Pages: 175
USD 2900.00
(Single User License)
Global Mucin 1 Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Mucin 1 market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 78
USD 4250.00
(Single User License)
Mucin 1- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Mucin 1 was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-25
Pages: 94
USD 3950.00
(Single User License)
Global Mucin 1 Market Research Report 2025
The global market for Mucin 1 was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-25
Pages: 87
USD 2900.00
(Single User License)
Global Mucin 1 Market Insights, Forecast to 2030
The global Mucin 1 market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published Date: 2024-04-26
Pages: 87
USD 4900.00
(Single User License)

Mucin 1- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Mucin 1 was estimated to be worth US$ 300 million in 2025 and is projected to reach US$ 620 million, growing at a CAGR of 10.8% from 2026 to 2032.
Published: 2026-05-30
Pages: 193
USD 3950.00 (Single User License)
Global Mucin 1 Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Mucin 1 market is projected to grow from US$ 300 million in 2025 to US$ 620 million by 2032, at a CAGR of 10.8% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-05-30
Pages: 240
USD 4900.00 (Single User License)
Global Mucin 1 Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Mucin 1 market size was US$ 300 million in 2025 and is forecast to reach a readjusted size of US$ 620 million by 2032 with a CAGR of 10.8% during the forecast period 2026-2032.
Published: 2026-05-30
Pages: 187
USD 4250.00 (Single User License)
Global Mucin 1 Market Research Report 2026
The global Mucin 1 market was valued at US$ 300 million in 2025 and is anticipated to reach US$ 620 million by 2032, at a CAGR of 10.8% from 2026 to 2032.
Published: 2026-05-30
Pages: 175
USD 2900.00 (Single User License)
Global Mucin 1 Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Mucin 1 market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 78
USD 4250.00 (Single User License)
Mucin 1- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Mucin 1 was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-25
Pages: 94
USD 3950.00 (Single User License)
Global Mucin 1 Market Research Report 2025
The global market for Mucin 1 was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-25
Pages: 87
USD 2900.00 (Single User License)
Global Mucin 1 Market Insights, Forecast to 2030
The global Mucin 1 market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published: 2024-04-26
Pages: 87
USD 4900.00 (Single User License)